Read < 1 minute
WHO opens its third emergency meeting on Ebola, pharmaceutical firm, Johnson and Johnson says it’s speeding up work on an experimental vaccine against the disease putting pressure on its main rivals in the vaccine race, GSK and NewLink Genetics to do the same. Maria Galang reports
